Dr. Tim Denison

Biography

Professor Tim Denison holds the Royal Academy of Engineering Chair in Emerging Technologies at the University of Oxford. He explores the fundamentals of physiological closed-loop systems and their applications in biomedical engineering. Prior to his current role, he was Vice President of Research & Core Technology at the Restorative Therapies Group of Medtronic, overseeing the development of neural interface technologies for treating neurological disorders. Denison has received numerous accolades, including membership in the Bakken Society, the Wallin Leadership Award, and being named a Fellow of the American Institute for Medical and Biological Engineering. His research focuses on brain engineering, including smart implants, non-invasive therapies, and development for resource-limited healthcare. Denison co-founded Amber Therapeutics to apply his research in clinical settings and has contributed to over a hundred patents in areas such as gene sequencing and brain-computer interfaces. He holds an A.B. in Physics from the University of Chicago and both an M.S. and Ph.D. in Electrical Engineering from MIT, along with an MBA as a Wallman Scholar. His mission is to deliver innovative therapies for intractable conditions, focusing on the practical applications of advanced bioelectronic technologies in the NHS and beyond.

Research Interests

Experience

Awards